Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...
A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.
A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.
Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...
Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells, ...
Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...
A major limitation of this type of CAR T cell therapy, called autologous therapy, is that the cells are taken from the ...
Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...
Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...